Daqo New Energy Corp ADR (DQ) deserves deeper analysis

While Daqo New Energy Corp ADR has overperformed by 10.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DQ fell by -0.62%, with highs and lows ranging from $30.85 to $12.40, whereas the simple moving average jumped by 6.99% in the last 200 days.

On April 30, 2025, HSBC Securities Downgraded Daqo New Energy Corp ADR (NYSE: DQ) to Hold. A report published by Goldman on April 15, 2025, Downgraded its rating to ‘Neutral’ for DQ. HSBC Securities August 27, 2024d its ‘Reduce’ rating to ‘Hold’ for DQ, as published in its report on August 27, 2024. HSBC Securities also rated the stock as ‘Reduce’.

Analysis of Daqo New Energy Corp ADR (DQ)

Further, the quarter-over-quarter decrease in sales is -70.16%, showing a negative trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Daqo New Energy Corp ADR’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -9.56% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.34, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and DQ is recording an average volume of 881.74K. On a monthly basis, the volatility of the stock is set at 5.12%, whereas on a weekly basis, it is put at 7.24%, with a gain of 27.36% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.13, showing decline from the present price of $19.32, which can serve as yet another indication of whether DQ is worth investing in or should be passed over.

How Do You Analyze Daqo New Energy Corp ADR Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.87%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 50.35% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

DQ shares are owned by institutional investors to the tune of 50.35% at present.

Hot this week

Nano X Imaging Ltd (NNOX) stock analysis: A simple moving average approach

While Nano X Imaging Ltd has overperformed by 2.15%,...

FTAI Aviation Ltd (FTAI)’s highs and lows: A closer look at its stock price fluctuations

While FTAI Aviation Ltd has underperformed by -1.55%, investors...

A year in review: QXO Inc (QXO)’s performance in the last year

While QXO Inc has underperformed by -0.14%, investors are...

EXK underperforms with a -7.63 decrease in share price

While Endeavour Silver Corp has underperformed by -7.63%, investors...

Technical analysis of Douglas Elliman Inc (DOUG) stock chart patterns

While Douglas Elliman Inc has overperformed by 2.94%, investors...

Topics

Nano X Imaging Ltd (NNOX) stock analysis: A simple moving average approach

While Nano X Imaging Ltd has overperformed by 2.15%,...

FTAI Aviation Ltd (FTAI)’s highs and lows: A closer look at its stock price fluctuations

While FTAI Aviation Ltd has underperformed by -1.55%, investors...

A year in review: QXO Inc (QXO)’s performance in the last year

While QXO Inc has underperformed by -0.14%, investors are...

EXK underperforms with a -7.63 decrease in share price

While Endeavour Silver Corp has underperformed by -7.63%, investors...

Technical analysis of Douglas Elliman Inc (DOUG) stock chart patterns

While Douglas Elliman Inc has overperformed by 2.94%, investors...

A stock that deserves closer examination: Anavex Life Sciences Corporation (AVXL)

While Anavex Life Sciences Corporation has overperformed by 2.00%,...

Aclaris Therapeutics Inc (ACRS) deserves deeper analysis

While Aclaris Therapeutics Inc has underperformed by -0.68%, investors...

Was Terns Pharmaceuticals Inc (TERN)’s session last reading good?

While Terns Pharmaceuticals Inc has overperformed by 13.25%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.